Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Other Publications
    • ajnr

User menu

  • Subscribe
  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

  • Subscribe
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds
Research Article

Genetics of Frontotemporal Dementia

F.W. Rohlfing and R.K. Tu
American Journal of Neuroradiology January 2017, 38 (1) 10-11; DOI: https://doi.org/10.3174/ajnr.A4972
F.W. Rohlfing
aFrom the Departments of Radiology (F.W.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for F.W. Rohlfing
R.K. Tu
bNeuroradiology (R.K.T.), George Washington University School of Medicine and Health Sciences, Washington, DC
cProgressive Radiology–Foxhall MRI (R.K.T.), Washington, DC.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for R.K. Tu
  • Article
  • Info & Metrics
  • References
  • PDF
Loading

ABBREVIATION:

FTD
frontotemporal dementia

History of Frontotemporal Dementia

In 1892, Arnold Pick, a neuropsychiatrist at the University of Prague, made the first description of frontotemporal dementia (FTD). In his case report, “On the relationship between senile atrophy of the brain and aphasia,” he described a 71-year-old man who developed progressive aphasia and apraxia. Upon autopsy, the patient's brain showed asymmetric atrophy.1

Pathologically, FTD is associated with atrophy of the frontal and/or temporal lobes, gliosis, neuronal swelling, and eventual microvacuolation.2,3 Pick bodies are hyperphosphorylated tau accumulations in the neuronal cytoplasm, which may be found with silver staining but are not pathognomonic for the disease.4 TAR DNA–binding proteins are hyperphosphorylated, ubiquinated, cleaved proteins and are the most commonly found neuropathology in FTD.5

FTD is an uncommon disease compared with other neurodegenerative disorders such as Alzheimer disease. However, in presenile dementia, FTD incidence is similar to that of Alzheimer disease. In a study of 50–59-year-old patients in Rochester, Minnesota, incidence of FTD cases and Alzheimer cases were both found to be 3.3/100,000 person years.6 In Cambridge, United Kingdom, FTD incidence was found to be 3.5/100,000 person years, whereas Alzheimer disease incidence was 4.2/100,000 person years.7 Although FTD is considered a presenile dementia, 20%–25% of patients with FTD are older than 65 years. The median survival is 6 ± 1.1 years.8,9

What are the Clinical Manifestations of Frontotemporal Dementia?

FTD has 3 main clinical manifestation groups based on dominant symptoms at diagnosis. The first is the frontal variant or behavioral variant, which may represent 70% of FTD.5 Frontal variant FTD results in alterations in interpersonal skills and behavior. Persons may show uninhibited behavior, disinhibition, apathy, or new obsessions or rituals, usually first noticed by a close contact of the patient.2,10

Progressive nonfluent aphasia variant is another manifestation group where patients present with word-finding difficulty. Speech can become nonfluent, but comprehension remains intact.2,10

Semantic dementia group is characterized by the loss of semantic memory. Patients may present with loss of word understanding and the inability to use or recall certain words. Instead, patients use less precise substitute terms and phrases. Speech remains fluent.2,8,10

In time, most manifestations of FTD converge and overlap, expressing multiple symptoms causing increased impairment.5

Are There Genetic Types of FTD?

Approximately 20%–40% of FTD cases have a family history of disease, and 10% of FTD cases are inherited in an autosomal dominant fashion.11 The most notable variants are found in MAPT (microtubule-associated protein tau), C9ORF72, and PGRN (progranulin).8,10

Mutations in the gene MAPT on chromosome 17 have been found to be associated with Pick bodies and FTD. MAPT mutations have been shown to be responsible for 11% of overall FTD cases.12

C9ORF72 mutations result in hexanucleotide repeat expansions; however, the mechanism behind this expansion is unclear, and the length of repeats has not been shown to correlate with severity. C9ORF72 mutations have shown to result in 6% of overall FTD cases.12

PGRN gene mutations on chromosome 17 likely result in lysosomal impairment and cause ubiquitin-positive cytoplasmic and intranuclear inclusions. PGRN mutations have been found to result in 10% of total FTD cases and 22% of familial FTD cases.13

Is There Diagnostic Testing for FTD?

Currently, diagnosis of FTD is based on clinical characteristic signs of continual change in behavior and language with the exclusion of delirium and psychotic disorders. Imaging is used to confirm the diagnosis by visualizing atrophy at the frontal and/or temporal lobes and exclude other diagnoses, including tumor, stroke, or infection.

What Is the Role of Imaging in FTD?

MR imaging is useful in excluding other diagnoses and can show atrophy of the frontal and/or temporal lobes with sparing of the posterior cortical areas to support the diagnosis of FTD.14

Other methods besides the standard T1 MR imaging have recently been used to evaluate FTD. Imaging of patients with frontal variant FTD has shown gray matter atrophy of the frontal and temporal lobes, with the right usually more affected than the left. Other affected structures include anterior cingulate, anterior insula, and subcortical structures. Patients with semantic FTD commonly present with atrophy of the temporal lobes, with the left more commonly affected than the right. Patients with progressive nonfluent aphasia FTD present initially with atrophy in the left inferior frontal lobe, insula, and premotor cortex.14

T2 and proton density–weighted MR imaging of FTD have shown increased white matter signal intensity in either the frontal or temporal lobes.3

DTI of frontal variant FTD has shown bilateral frontal and temporal lobe changes of the white matter. Semantic FTD has shown asymmetrical (left more than right) changes. Progressive nonfluent aphasia FTD has shown white matter changes in the dorsal language pathways.14

Resting-state fMRI has been used to analyze changes in FTD. However, results have been contradictory and inconclusive.14

Arterial spin-labeling perfusion MR imaging in frontal variant FTD has shown hypoperfusion in the frontal regions, anterior cingulate, and thalamus.14

SPECT and PET in FTD show hypometabolism in the frontal and temporal lobes, with progressive nonfluent aphasia variant showing more hypometabolism in the temporal lobes and frontal variant FTD showing more hypoperfusion in the frontal lobes. This technique may be useful and assist in diagnosis when MR does not show atrophy of frontal or temporal lobes.2,14

Conclusions

Diagnosis of FTD still rests on a characteristic clinical examination. Of the imaging modalities, SPECT and PET studies appear to be a sensitive diagnostic tool. Structural imaging is contributory when atrophy is present; however, characteristic signs of FTD may not be present early in the disease process. Genetic and idiopathic forms of FTD have similar imaging and genetic mutations, suggesting a common pathophysiology.

References

  1. 1.↵
    1. Pearce J
    . Pick's disease. J Neurol Neurosurg Psychiatry 2003;74:169 doi:10.1136/jnnp.74.2.169 pmid:12531941
    FREE Full Text
  2. 2.↵
    1. Kirshner H
    . Frontotemporal dementia and primary progressive aphasia: an update. Curr Neurol Neurosci Rep 2010;10:504–11 doi:10.1007/s11910-010-0145-z pmid:20717853
    CrossRefPubMed
  3. 3.↵
    1. Kitagaki H,
    2. Mori E,
    3. Hirono N, et al
    . Alteration of white matter MR signal intensity in frontotemporal dementia. AJNR Am J Neuroradiol 1997;18:367–78 pmid:9111678
    Abstract
  4. 4.↵
    1. Spillantini MG,
    2. Goedert M
    . Tau pathology and neurodegeneration. Lancet Neurol 2013;12:609–22 doi:10.1016/S1474-4422(13)70090-5 pmid:23684085
    CrossRefPubMed
  5. 5.↵
    1. Seltman RE,
    2. Matthews BR
    . Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management. CNS Drugs 2012;26:841–70 doi:10.2165/11640070-000000000-00000 pmid:22950490
    CrossRefPubMed
  6. 6.↵
    1. Knopman DS,
    2. Petersen RC,
    3. Edland SD, et al
    . The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology 2004;62:506–08 doi:10.1212/01.wnl.0000106827.39764.7e pmid:14872045
    CrossRefPubMed
  7. 7.↵
    1. Mercy L,
    2. Hodges JR,
    3. Dawson K, et al
    . Incidence of early-onset dementias in Cambridgeshire, United Kingdom. Neurology 2008;71:1496–99 doi:10.1212/01.wnl.0000334277.16896.fa pmid:18981371
    Abstract/FREE Full Text
  8. 8.↵
    1. Weder ND,
    2. Aziz R,
    3. Wilkins K, et al
    . Frontotemporal dementias: a review. Ann Gen Psychiatry 2007;6:15 doi:10.1186/1744-859X-6-15 pmid:17565679
    CrossRefPubMed
  9. 9.↵
    1. Hodges JR,
    2. Davies R,
    3. Xuereb J, et al
    . Survival in frontotemporal dementia. Neurology 2003;61:349–54 doi:10.1212/01.wnl.0000078928.20107.52 pmid:12913196
    Abstract/FREE Full Text
  10. 10.↵
    1. Warren JD,
    2. Rohrer JD,
    3. Rossor MN
    . Frontotemporal dementia. BMJ 2013;347:f4827 doi:10.1136/bmj.f4827 pmid:23920254
    FREE Full Text
  11. 11.↵
    1. Rohrer JF,
    2. Guerreiro R,
    3. Vandrovcova J, et al
    . The heritability and genetics of frontotemporal lobar degeneration. Neurology 2009;73:1451–56 doi:10.1212/WNL.0b013e3181bf997a pmid:19884572
    Abstract/FREE Full Text
  12. 12.↵
    1. Seelaar H,
    2. Kamphorst W,
    3. Rosso SM, et al
    . Distinct genetic forms of frontotemporal dementia. Neurology 2008;71:1220–26 doi:10.1212/01.wnl.0000319702.37497.72 pmid:18703462
    Abstract/FREE Full Text
  13. 13.↵
    1. Gass J,
    2. Cannon A,
    3. Mackenzie IR, et al
    . Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 2006;15:2988–3001 doi:10.1093/hmg/ddl241 pmid:16950801
    Abstract/FREE Full Text
  14. 14.↵
    1. Rohrer JD,
    2. Rosen HJ
    . Neuroimaging in frontotemporal dementia. Int Rev Psychiatry 2013;25:221–29 doi:10.3109/09540261.2013.778822 pmid:23611351
    CrossRefPubMed
  • © 2017 by American Journal of Neuroradiology
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 38 (1)
American Journal of Neuroradiology
Vol. 38, Issue 1
1 Jan 2017
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Genetics of Frontotemporal Dementia
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Genetics of Frontotemporal Dementia
F.W. Rohlfing, R.K. Tu
American Journal of Neuroradiology Jan 2017, 38 (1) 10-11; DOI: 10.3174/ajnr.A4972

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Genetics of Frontotemporal Dementia
F.W. Rohlfing, R.K. Tu
American Journal of Neuroradiology Jan 2017, 38 (1) 10-11; DOI: 10.3174/ajnr.A4972
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • ABBREVIATION:
    • History of Frontotemporal Dementia
    • What are the Clinical Manifestations of Frontotemporal Dementia?
    • Are There Genetic Types of FTD?
    • Is There Diagnostic Testing for FTD?
    • What Is the Role of Imaging in FTD?
    • Conclusions
    • References
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • 'Serious science: a response to Kleiderman, Ravitsky and Knoppers
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Similar Articles

Advertisement

News and Updates

  • Lucien Levy Best Research Article Award
  • Thanks to our 2020 Distinguished Reviewers
  • Press Releases

Resources

  • Evidence-Based Medicine Level Guide
  • How to Participate in a Tweet Chat
  • AJNR Podcast Archive
  • Ideas for Publicizing Your Research
  • Librarian Resources
  • Terms and Conditions

Opportunities

  • Share Your Art in Perspectives
  • Get Peer Review Credit from Publons
  • Moderate a Tweet Chat

American Society of Neuroradiology

  • Neurographics
  • ASNR Annual Meeting
  • Fellowship Portal
  • Position Statements

© 2021 by the American Society of Neuroradiology | Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire